The third of our 2016 series of climate seminars included talks from Dr Richard Fraser and Professor Paul Linden. Recordings of the first two seminars in the series may be found here (4 Feb) and here (11 Feb).

A Policy Workshop held in collaboratioin with Friends of the Earth, the Nesta Health Lab and the Cambridge Institute of Public Health, brought together a wide range of Policy Fellows from the health and environment sectors to discuss the role of social movements, innovation, and impact at scale.

A Policy Workshop organised in partnership with the Centre for Law, Medicine and Life Sciences brought together experts from the public and private sectors working on issues around genomics, synthetic biology, intellectual property (IP) law and policy.

On 24 November 2015 CSaP ran a policy workshop on the subject of 'How do you make Europe a global pro-innovation actor?' The workshop came at an important time for the EU and its member states.

This event with TechUK considered technological innovation in Europe in a complex policy landscape.

On 18 September 2015, CSaP teamed up with Cambridge Big Data and the Royal Statistical Society to run a workshop exploring how data science and ‘Big Data’ can help inform and improve public policy.

Following a workshop earlier this year, the Centre for Law, Medicine and Life Sciences (Faculty of Law, University of Cambridge) together with CSaP published a report this week on the debates, policy frameworks and recommendations for further research discussed at that meeting.

The Centre for Science and Policy is delighted to welcome Professor Jatin Nathwani as a Visiting Research Fellow in July 2015.

The eighth meeting of CSaP's Policy Leaders Fellowship focussed on 'Infection', with a talk by Dr Nigel Collier.

On 1 May the Centre for Science and Policy hosted a workshop in association with the Centre for Law Medicine and Life Sciences at the University of Cambridge. The overall aim was to identify and discuss key issues in intellectual property (IP) policies and strategies affecting the development of genomic medicine.